Match tier
Listed
Presence
Current · Arkansas
Last published
2023
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
S
Sarenthia M. Epps
Pulmonary and critical care physician
Also affiliated: University of Arkansas Medical Center (2022)
4 h-index
8 pubs
43 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sarenthia M. Epps' research investigates the intersection of infectious diseases, particularly COVID-19, with broader health and environmental factors. Her work has explored the increased risk of acute kidney injury associated with SARS-CoV-2 infection, noting a bimodal age distribution for this complication. Epps has also examined the association between tocilizumab use in critically ill COVID-19 patients and an elevated risk of fungal infections, especially in those with acute renal failure. Her publications also touch upon the potential toxic synergy between COVID-19 and climate change, as well as drug-induced lung injury and arterial thrombus in COVID-19 patients. Epps collaborates with researchers at the University of Arkansas for Medical Sciences, including Nikhil Meena, William T. Atchley, Rajani Jagana, and Barrett J. Burger.
Metrics
- h-index: 4
- Publications: 8
- Citations: 43
Positions
-
Pulmonary and critical care physician publications 2020–2023University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
-
A 34-Year-Old Man With Lightheadedness and Dyspnea (2022)
-
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)
-
Unprecedented: the toxic synergism of Covid-19 and climate change (2020)
Collaboration Network
Top Collaborators
Nikhil Meena
University of Arkansas for Medical Sciences
4 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Barrett J. Burger
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Víctor M. Cárdenas
University of Arkansas for Medical Sciences (US)
3 shared publications
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Rajani Jagana
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
William T. Atchley
University of Arkansas for Medical Sciences
3 shared publications
In database
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
Manish Joshi
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- Unprecedented: the toxic synergism of Covid-19 and climate change
José Luís Hernández Cáceres
University of Arkansas for Medical Sciences (US)
1 shared publication
- Unprecedented: the toxic synergism of Covid-19 and climate change
Steven Ko
University of Arkansas for Medical Sciences
1 shared publication
In database
- Unprecedented: the toxic synergism of Covid-19 and climate change
Thaddeus Bartter
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- Unprecedented: the toxic synergism of Covid-19 and climate change
Abhishek Kumar
University of Nevada, Las Vegas (US)
1 shared publication
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Susanne K. Jeffus
University of Arkansas for Medical Sciences
1 shared publication
In database
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Jose Diego Caceres
University of Arkansas for Medical Sciences
1 shared publication
In database
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Jonathan Killam
Northwell Health (US)
1 shared publication
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Anand N. Venkata
University of Arkansas Medical Center
1 shared publication
In database
- A 34-Year-Old Man With Lightheadedness and Dyspnea
Similar Researchers
Based on overlapping research topics
Amulya Kasireddy
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Acute Kidney Injury
Heba Mousa
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Microbial infections and disease research
Jorge Brito
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Harmeen Goraya
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Acute Kidney Injury
Climate variability and models
Anushareddy Muddasani
University of Arkansas for Medical Sciences
Acute Kidney Injury
Microbial infections and disease research
Pharmacological Effects and Toxicity Studies
Ryan K Dare
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Microbial infections and disease research